100 related articles for article (PubMed ID: 1218)
1. Tissue metabolites of trifluorperazine, fluphenazine, prochlorperazine, and perphenazine. Kinetics in chronic treatment.
Gaertner HJ; Liomin G; Villumsen D; Bertele R; Breyer U
Drug Metab Dispos; 1975; 3(6):437-44. PubMed ID: 1218
[TBL] [Abstract][Full Text] [Related]
2. Tissue accumulation of metabolites during chronic administration of piperazine-substituted phenothiazine drugs.
Breyer U; Gaertner HJ
Adv Biochem Psychopharmacol; 1974; 9(0):167-73. PubMed ID: 4151761
[No Abstract] [Full Text] [Related]
3. Tissue metabolites of trifluoperazine, fluphenazine, prochlorperazine, and perphenazine in the rat: indentification and synthesis.
Breyer U; Prox A; Bertele R; Gaertner HJ
J Pharm Sci; 1974 Dec; 63(12):1842-8. PubMed ID: 4449013
[No Abstract] [Full Text] [Related]
4. Metabolism of trifluoperazine, fluphenazine, prochlorperazine and perphenazine in rats: in vitro and urinary metabolites.
Gaertner HJ; Breyer U; Liomin G
Biochem Pharmacol; 1974 Jan; 23(2):303-11. PubMed ID: 4813347
[No Abstract] [Full Text] [Related]
5. Formation of identical metabolites from piperazine- and dimethylamino-substituted phenothiazine drugs in man, rat and dog.
Breyer U; Gaertner HJ; Prox A
Biochem Pharmacol; 1974 Jan; 23(2):313-22. PubMed ID: 4813348
[No Abstract] [Full Text] [Related]
6. The rat brain as a "deep compartment" in the kinetics of a common metabolite of prochlorperazine and perphenazine.
Jahns I; Breyer U
Drug Metab Dispos; 1976; 4(6):522-9. PubMed ID: 11973
[TBL] [Abstract][Full Text] [Related]
7. In vivo piperazine ring degradation in neuroleptic and antihistaminic drugs.
Gaertner HJ; Breyer U
Arzneimittelforschung; 1972 Jun; 22(6):1084-5. PubMed ID: 4403218
[No Abstract] [Full Text] [Related]
8. Metabolism and disposition of trifluoperazine in the rat. II. Kinetics after oral and intravenous administration in acutely and chronically treated animals.
Schmalzing G
Drug Metab Dispos; 1977; 5(2):104-15. PubMed ID: 15802
[TBL] [Abstract][Full Text] [Related]
9. Microsomal mixed-function amine oxidase. Oxidation products of piperazine-substituted phenothiazine drugs.
Sofer SS; Ziegler DM
Drug Metab Dispos; 1978; 6(3):232-9. PubMed ID: 26542
[TBL] [Abstract][Full Text] [Related]
10. PHENOTHIAZINE DERIVATIVES.
DELGADO JN; COSGROVE FP; ISAACSON EI
Tex State J Med; 1964 Mar; 60():315-8. PubMed ID: 14131729
[No Abstract] [Full Text] [Related]
11. Studies of flavin-adenine dinucleotide-requiring enzymes and phenothiazines. II. Structural requirements for D-amino acid oxidase inhibition.
Gabay S; Harris SR
Biochem Pharmacol; 1966 Mar; 15(3):317-22. PubMed ID: 4380375
[No Abstract] [Full Text] [Related]
12. NTP technical report on the toxicity and metabolism studies of chloral hydrate (CAS No. 302-17-0). Administered by gavage to F344/N rats and B6C3F1 mice.
Beland FA
Toxic Rep Ser; 1999 Aug; (59):1-66, A1-E7. PubMed ID: 11803702
[TBL] [Abstract][Full Text] [Related]
13. In vitro anticancer activity of fluphenazine, perphenazine and prochlorperazine. A review.
Otręba M; Kośmider L
J Appl Toxicol; 2021 Jan; 41(1):82-94. PubMed ID: 32852120
[TBL] [Abstract][Full Text] [Related]
14. Receptor binding potencies of chlorpromazine, trifluoperazine, fluphenazine and their 10-N-substituted analogues.
Savelyeva MV; Baldenkov GN; Kaverina NV
Biomed Biochim Acta; 1988; 47(12):1085-7. PubMed ID: 2855395
[TBL] [Abstract][Full Text] [Related]
15. In vitro phototoxicity of phenothiazines: involvement of stable UVA photolysis products formed in aqueous medium.
Miolo G; Levorato L; Gallocchio F; Caffieri S; Bastianon C; Zanoni R; Reddi E
Chem Res Toxicol; 2006 Jan; 19(1):156-63. PubMed ID: 16411669
[TBL] [Abstract][Full Text] [Related]
16. NTP Toxicology and Carcinogenesis Studies of 1-Amino-2,4-Dibromoanthraquinone (CAS No. 81-49-2) in F344/N Rats and B6C3F1 Mice (Feed Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1996 Aug; 383():1-370. PubMed ID: 12692653
[TBL] [Abstract][Full Text] [Related]
17. NTP Toxicology and Carcinogenesis Studies of Pentachloroanisole (CAS No. 1825-21-4) in F344 Rats and B6C3F1 Mice (Feed Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1993 Apr; 414():1-284. PubMed ID: 12616284
[TBL] [Abstract][Full Text] [Related]
18. Phenothiazine drugs: structure-activity relationships explained by a conformation that mimics dopamine.
Feinberg AP; Snyder SH
Proc Natl Acad Sci U S A; 1975 May; 72(5):1899-903. PubMed ID: 239403
[TBL] [Abstract][Full Text] [Related]
19. Metabolism and disposition of trifluoperazine in the rat. I. A thin-layer chromatographic method for the measurement of trifluoperazine and its metabolites in rat tissues.
Breyer U; Schmalzing G
Drug Metab Dispos; 1977; 5(2):97-103. PubMed ID: 15817
[TBL] [Abstract][Full Text] [Related]
20. Orally active inhibitors of human leukocyte elastase. III. Identification and characterization of metabolites of L-694,458 by liquid chromatography-tandem mass spectrometry.
Luffer-Atlas D; Vincent SH; Painter SK; Arison BH; Stearns RA; Chiu SH
Drug Metab Dispos; 1997 Aug; 25(8):940-52. PubMed ID: 9280402
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
